NASDAQ:CLVRW Clever Leaves (CLVRW) Stock Price, News & Analysis → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free CLVRW Stock Alerts $0.03 0.00 (-6.59%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share Today's Range$0.03▼$0.0450-Day Range$0.03▼$0.0552-Week Range$0.01▼$0.05Volume4,100 shsAverage Volume18,253 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsShort InterestSocial Media Get Clever Leaves alerts: Email Address Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. About Clever Leaves Stock (NASDAQ:CLVRW)Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.Read More CLVRW Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLVRW Stock News HeadlinesApril 1, 2024 | investorplace.comCLVR Stock Earnings: Clever Leaves Holdings Misses Revenue for Q4 2023November 11, 2023 | insidermonkey.comClever Leaves Holdings Inc. (NASDAQ:CLVR) Q3 2023 Earnings Call TranscriptSee More Headlines Receive CLVRW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clever Leaves and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolNASDAQ:CLVRW CUSIPN/A CIK1819615 Webwww.cleverleaves.com Phone561 634 7430FaxN/AEmployees296Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$17.42 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Andres Fajardo (Age 46)Co-Founder, CEO & Director Comp: $232.02kMr. Henry R. Hague III (Age 52)Chief Financial Officer Comp: $311.02kMr. Julian Wilches (Age 45)Chief Regulatory Officer Comp: $202.49kMr. Gustavo EscobarChief Operating OfficerMs. Marta Pinto LeiteGeneral Counsel & Corporate SecretaryMr. Andrew MillerHead of Business DevelopmentMr. Camilo BohorquezHead of ColombiaMs. Caroline KliessManaging Director of GermanyJackie KeshnerInvestor Relations ExecutiveMore ExecutivesKey CompetitorsAlvotechNASDAQ:ALVOWBiofronteraNASDAQ:BFRIWCyclo TherapeuticsNASDAQ:CYTHWProcaps GroupNASDAQ:PROCWSunshine BiopharmaNASDAQ:SBFMWView All Competitors CLVRW Stock Analysis - Frequently Asked Questions How have CLVRW shares performed in 2024? Clever Leaves' stock was trading at $0.0177 at the beginning of 2024. Since then, CLVRW shares have increased by 84.2% and is now trading at $0.0326. View the best growth stocks for 2024 here. Are investors shorting Clever Leaves? Clever Leaves saw a decrease in short interest in April. As of April 15th, there was short interest totaling 3,700 shares, a decrease of 63.7% from the March 31st total of 10,200 shares. Based on an average daily volume of 15,200 shares, the days-to-cover ratio is presently 0.2 days. View Clever Leaves' Short Interest. How do I buy shares of Clever Leaves? Shares of CLVRW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CLVRW) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clever Leaves Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.